SP1 and ovarian cancer: Specific chemical inhibitors against four molecules linked with EMT—that is, Smad 2/3, ILK, AP-1, and SP-1—were added to ovarian cancer cells prior to their exposure to the malignant ascites to identify the signaling pathway(s) responsible for the induction of this process.